| 今开：12.63 | 昨收：12.7 |
| 最高：12.65 | 最低：12.15 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.50814308E8 |
夹头博士DrChuck2023-07-29 21:35
回复@陈达美股投资: 相当专业，$Nevro(NVRO)$ 不幸的落入了苟延残喘的境地，不过21年大放水时也超过了霸道总裁的情节。估值确实是科学和艺术的结合，严谨分析财报和模型的科学家总被疯狂的市场艺术家调戏～//@陈达美股投资:回复@Hello朱:我知乎上那篇巨长的手把手教你DCF，有网友反映被大学corpora...查看全文
Nevro(NVRO)04-13 04:55
$Nevro(NVRO)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-044100 Act: 34 Size: 6 MB 网页链接查看全文
Nevro(NVRO)04-16 04:15
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000207 Size: 4 KB 网页链接查看全文
Nevro(NVRO)04-13 04:55
$Nevro(NVRO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-044108 Act: 34 Size: 1 MB 网页链接查看全文
Nevro(NVRO)04-09 04:25
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000204 Size: 4 KB 网页链接查看全文
Nevro(NVRO)04-03 07:15
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000201 Size: 4 KB 网页链接查看全文
Nevro(NVRO)04-03 07:15
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000202 Size: 8 KB 网页链接查看全文
Nevro(NVRO)04-03 07:15
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000200 Size: 4 KB 网页链接查看全文
夹头博士DrChuck2023-07-29 21:35
回复@陈达美股投资: 相当专业，$Nevro(NVRO)$ 不幸的落入了苟延残喘的境地，不过21年大放水时也超过了霸道总裁的情节。估值确实是科学和艺术的结合，严谨分析财报和模型的科学家总被疯狂的市场艺术家调戏～//@陈达美股投资:回复@Hello朱:我知乎上那篇巨长的手把手教你DCF，有网友反映被大学corpora...查看全文
蹊之美股生物医药2021-08-06 22:10
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Profound Medical (NASDAQ:PROF) +29%
STAAR Surgical (NASDAQ:STAA) +20%
AdaptHealth (NASDAQ:AHCO) +15%
Flora Growth (NASDAQ:FLGC) +12%
Invacare (NYSE:IVC) +14%
L...查看全文
郁闷的鞋套-2021-07-20 12:42
$Nevro(NVRO)$ 2021年7月19日，Nevro公司宣布，其专有的10 kHZ脊髓刺激（SCS）“Senza”系统，已获得美国FDA批准，用于治疗疼痛性糖尿病神经病变（PDN）引起的慢性疼痛。新闻稿指出，这是FDA批准的首款以PDN为适应症的脊髓刺激系统。该公司将根据本次批准，推出的名为“HFX”的PDN治疗相关产品。HF...查看全文
智通财经APP获悉，鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购，摩根大通分析师Robbie Marcus列出了潜在的收购目标，包括：英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-21-002066 Act: 34 Size: 13 KB 网页链接
$Nevro(NVRO)$ 内部交易: 2021-01-11,Chief Commercial Officer,Pellegrini Niamh Louise ,卖出,750普通股, $169.80
$Nevro(NVRO)$ 内部交易: 2021-01-11,Chief Commercial Officer,Pellegrini Niamh Louise ,期权,750普通股, $64.95
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-21-000977 Size: 8 KB 网页链接
$Nevro(NVRO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-000754 Act: 34 Size: 188 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-21-000322 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-21-000326 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-21-000323 Size: 4 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-21-000325 Size: 8 KB 网页链接
$Nevro(NVRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-21-000321 Size: 4 KB 网页链接